rss
08-02-2016, 12:28 AM
Bigfoot Biomedical’s Diabetes Management System Going on Trial
http://www.medgadget.com/wp-content/uploads/2016/07/Bigfoot-smartloop.pngBigfoot Biomedical is a company working on introducing an “artificial pancreas” for Type 1 diabetics who are on insulin therapy. The company has developed its own algorithms that control the delivery of insulin by a pump based on readings from a continuous glucose monitor (CGM). **w these algorithms are about to be tested in a clinical trial thanks to an FDA Investigational Device Exemption and enrollment of initial patients.
Bigfoot’s “smartloop” automated insulin delivery system relies on Dexcom’s G5 CGM, a product that last week*received a positive vote from an FDA panel to be used as a replacement for traditional finger prick-based blood glucose testing. The smartloop receives readings from the G5 every five minutes and, though the company isn’t saying it, probably also takes manually inputted data from patients via a smartphone regarding diet and exercise. This is used to regularly adjust when to deliver a dose of insulin in order to keep the patient within a healthy glucose range.
Here’s an interesting **te, according to the company, of the roots of*Bigfoot Biomedical:
Motivated by a desire to improve the lives of their children, Jeffrey Brewer, former CEO of JDRF International, and Bryan Mazlish, the mysterious “Bigfoot” in Dan Hurley’s piece for Wired Magazine (http://www.wired.com/2014/12/diabetes-patients-hacking-together-diy-bionic-pancreases/), founded Bigfoot Biomedical in **vember 2014. Moving with unprecedented speed in medical device development, over the past 20 months they’ve assembled a team of 40 people and are driving toward commercialization of a cutting edge approach to improving the lives of people with T1D.
Link:*Bigfoot Biomedical’s homepage… (https://www.bigfootbiomedical.com/)
Via: Bigfoot Biomedical… (https://www.bigfootbiomedical.com/first-clinical-trial/)
This post Bigfoot Biomedical’s Diabetes Management System Going on Trial (http://www.medgadget.com/2016/08/bigfoot-diabetes-system.html) appeared first on Medgadget (http://www.medgadget.com).
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=**n_gHlwIqo:wiQ52nWJmv4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=**n_gHlwIqo:wiQ52nWJmv4:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=**n_gHlwIqo:wiQ52nWJmv4:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=**n_gHlwIqo:wiQ52nWJmv4:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/**n_gHlwIqo
http://www.medgadget.com/wp-content/uploads/2016/07/Bigfoot-smartloop.pngBigfoot Biomedical is a company working on introducing an “artificial pancreas” for Type 1 diabetics who are on insulin therapy. The company has developed its own algorithms that control the delivery of insulin by a pump based on readings from a continuous glucose monitor (CGM). **w these algorithms are about to be tested in a clinical trial thanks to an FDA Investigational Device Exemption and enrollment of initial patients.
Bigfoot’s “smartloop” automated insulin delivery system relies on Dexcom’s G5 CGM, a product that last week*received a positive vote from an FDA panel to be used as a replacement for traditional finger prick-based blood glucose testing. The smartloop receives readings from the G5 every five minutes and, though the company isn’t saying it, probably also takes manually inputted data from patients via a smartphone regarding diet and exercise. This is used to regularly adjust when to deliver a dose of insulin in order to keep the patient within a healthy glucose range.
Here’s an interesting **te, according to the company, of the roots of*Bigfoot Biomedical:
Motivated by a desire to improve the lives of their children, Jeffrey Brewer, former CEO of JDRF International, and Bryan Mazlish, the mysterious “Bigfoot” in Dan Hurley’s piece for Wired Magazine (http://www.wired.com/2014/12/diabetes-patients-hacking-together-diy-bionic-pancreases/), founded Bigfoot Biomedical in **vember 2014. Moving with unprecedented speed in medical device development, over the past 20 months they’ve assembled a team of 40 people and are driving toward commercialization of a cutting edge approach to improving the lives of people with T1D.
Link:*Bigfoot Biomedical’s homepage… (https://www.bigfootbiomedical.com/)
Via: Bigfoot Biomedical… (https://www.bigfootbiomedical.com/first-clinical-trial/)
This post Bigfoot Biomedical’s Diabetes Management System Going on Trial (http://www.medgadget.com/2016/08/bigfoot-diabetes-system.html) appeared first on Medgadget (http://www.medgadget.com).
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=**n_gHlwIqo:wiQ52nWJmv4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=**n_gHlwIqo:wiQ52nWJmv4:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=**n_gHlwIqo:wiQ52nWJmv4:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=**n_gHlwIqo:wiQ52nWJmv4:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/**n_gHlwIqo